SPXU vs VHT
ProShares UltraPro Short S&P500 vs Vanguard Health Care ETF
SPXU$34.75
ProShares UltraPro Short S&P500
3x inverse daily performance of the S&P 500.
Expense: 0.90%Yield: 6.05%
VHT$347.68
Vanguard Health Care ETF
US health care sector stocks.
Expense: 0.09%Yield: 1.35%
Quick take
- • VHT has the lower expense ratio at 0.09% vs 0.90% for SPXU.
- • SPXU pays a higher dividend yield (6.05%).
Side-by-side metrics
| Metric | SPXU | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.90% | 0.09% |
Dividend yield Trailing 12-month yield. | 6.05% | 1.35% |
AUM Assets under management — bigger funds are typically more liquid. | $428M | $23.73B |
YTD return | -25.45% | 22.17% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | -2.62 | 0.46 |
P/E ratio | — | 32.41 |
Last price | $34.75 | $347.68 |
Inception | — | — |
Issuer | ProShares | Vanguard |
SPXU top holdings
Top holdings · SPXU
| IQMM | ProShares GENIUS Money Market ETF | 89.37% |
VHT top holdings
Top holdings · VHT
| LLY | Eli Lilly and Co | 12.93% |
| JNJ | Johnson & Johnson | 8.78% |
| ABBV | AbbVie Inc | 6.45% |
| MRK | Merck & Co Inc | 5.01% |
| UNH | UnitedHealth Group Inc | 4.65% |
| TMO | Thermo Fisher Scientific Inc | 3.50% |
| AMGN | Amgen Inc | 3.18% |
| GILD | Gilead Sciences Inc | 2.58% |
| ABT | Abbott Laboratories | 2.40% |
| PFE | Pfizer Inc | 2.27% |
Sector breakdown · VHT
Technology0.0%
Financial Services0.0%
Industrials0.0%
Healthcare100.0%
About SPXU
SPXU (ProShares UltraPro Short S&P500) is 3x inverse daily performance of the S&P 500. Managed by ProShares, the fund carries $428M in assets under management, an expense ratio of 0.90%, a dividend yield of 6.05%. Its largest holding is ProShares GENIUS Money Market ETF (IQMM), which represents 89.4% of the portfolio.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $23.7B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.35%. Its largest holding is Eli Lilly and Co (LLY), which represents 12.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.